Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.

[1]  A. Coats,et al.  Ethical authorship and publishing. , 2009, International journal of cardiology.

[2]  J. Bauersachs,et al.  Endothelial dysfunction in heart failure. , 2008, Pharmacological reports : PR.

[3]  D. Waters,et al.  Effects of statin therapy on the development and progression of heart failure: mechanisms and clinical trials. , 2006, Journal of cardiac failure.

[4]  C. Frampton,et al.  Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure , 2006, Heart.

[5]  M. Spiecker,et al.  Endothelial Function in the Forearm Circulation of Patients with the Metabolic Syndrome – Effect of Different Lipid-Lowering Regimens , 2005, Cardiology.

[6]  C. Tack,et al.  Effects of rosuvastatin on endothelial function in patients with familial combined hyperlipidaemia (FCH) , 2005, Current medical research and opinion.

[7]  W. März,et al.  Simvastatin Versus Ezetimibe: Pleiotropic and Lipid-Lowering Effects on Endothelial Function in Humans , 2005, Circulation.

[8]  C. Stefanadis,et al.  Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques , 2005, Heart.

[9]  C. Stefanadis,et al.  Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure. , 2005, Atherosclerosis.

[10]  C. Tsioufis,et al.  Effects of atorvastatin on reactive hyperaemia and the thrombosis–fibrinolysis system in patients with heart failure , 2004, Heart.

[11]  C. Stefanadis,et al.  Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy. , 2004, International journal of cardiology.

[12]  D. Mele,et al.  Oxidative stress during myocardial ischaemia and heart failure. , 1998, Current pharmaceutical design.

[13]  S. Anker,et al.  Statins and the Role of Nitric Oxide in Chronic Heart Failure , 2004, Heart Failure Reviews.

[14]  F. Recchia,et al.  Preservation of NO production by statins in the treatment of heart failure. , 2003, Cardiovascular research.

[15]  S. Goldman,et al.  Simvastatin restores endothelial NO-mediated vasorelaxation in large arteries after myocardial infarction. , 2002, American journal of physiology. Heart and circulatory physiology.

[16]  U. Elkayam,et al.  Impaired endothelium-mediated vasodilation in heart failure: clinical evidence and the potential for therapy. , 2002, Journal of cardiac failure.

[17]  A. M. Lefer,et al.  Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease. , 2001, Cardiovascular research.

[18]  H. Drexler,et al.  Endothelial dysfunction in human disease. , 1999, Journal of molecular and cellular cardiology.

[19]  P. Singal,et al.  Role of oxidative stress in transition of hypertrophy to heart failure. , 1996, Journal of the American College of Cardiology.